The present invention relates to binding proteins, such as antibodies and antibody fragments specific for the toxic prefibrillar aggregates of amyloid-beta peptides, and uses thereof in the diagnosis and prevention, prophylaxis and/or treatment of amyloid diseases such as Alzheimers disease and related disorders.